Related Experiment Video
Updated: May 9, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Variation in resource use and readmission for diabetic ketoacidosis in children's hospitals
Joel S Tieder1, Lisa McLeod, Ron Keren
1Division of Inpatient Medicine, Department of Pediatrics, University of Washington and Seattle Children’s Hospital, Seattle, Washington 98105, USA. joel.tieder@seattlechildrens.org
Insights
Diabetic ketoacidosis (DKA) readmissions are common in children, with significant variations in hospital costs and length of stay (LOS) across US children's hospitals. Further research is needed to identify cost-effective diabetes management strategies.
Area of Science:
- Pediatric Endocrinology
- Healthcare Management
- Health Services Research
Background:
- Diabetic ketoacidosis (DKA) is a serious complication of diabetes in children.
- Understanding variations in hospital resource utilization and readmission rates for DKA is crucial for improving patient outcomes and managing healthcare costs.
Purpose of the Study:
- To characterize the variation in hospital resource utilization and readmission rates for diabetic ketoacidosis (DKA) among US children's hospitals.
- To identify factors contributing to differences in cost, length of stay (LOS), and readmission for DKA.
Main Methods:
- Retrospective cohort study of children aged 2-18 years diagnosed with DKA.
- Data collected from 38 children's hospitals between 2004 and 2009.
- Outcomes assessed: total standardized cost, overall and non-ICU length of stay (LOS), and 30- and 365-day DKA readmissions.
Main Results:
- 24,890 DKA admissions analyzed; 20.3% were readmissions within one year.
- Mean hospital costs varied significantly ($7142), as did LOS (2.5 days) and readmission rates (18.7% within 365 days).
- Hospital bed days (overall and non-ICU) constituted the majority of costs and explained resource use variation; significant inter-hospital differences persisted after adjustment for patient characteristics.
Conclusions:
- Readmission for DKA within a year is frequent in pediatric populations.
- Substantial variability exists across US children's hospitals in resource use, LOS, and DKA readmission rates.
- Further research is essential to understand these disparities and develop cost-effective diabetes management strategies across the care continuum.
Objective:
We sought to characterize variation in hospital resource utilization and readmission for diabetic ketoacidosis (DKA) across US children's hospitals.
Methods:
The study sample included a retrospective cohort of children aged 2 to 18 years with a diagnosis of DKA at 38 children's hospitals between 2004 and 2009. The main outcomes were resource utilization as determined by total standardized cost per hospitalization, overall and non-ICU length of stay (LOS), and readmission for DKA within 30 and 365 days.
Results:
There were 24,890 DKA admissions, and 20.3% of these were readmissions within 1 year. The mean hospital-level total standardized cost was $7142 (range $4125-$11,916). The mean hospital-level LOS was 2.5 days (1.5-3.7), and the non-ICU portion was 1.9 days (0.7-2.7). The mean hospital-level readmission within 365 days was 18.7% (6.5%-41.1%) and within 30 days was 2.5% (0.0%-7.1%). Hospital bed days overall, and in particular the non-ICU portion, accounted for the majority of the total standardized cost per hospitalization (overall 57%; non-ICU 36%) and explained most of the variation in resource use. Even after adjusting for difference in patient characteristics across hospitals, widespread differences existed across hospitals in total standardized cost, LOS, and readmission rates (P < .001).
Conclusions:
Readmission for DKA within a year of hospitalization is common. US children's hospitals vary widely in resource use, hospital LOS, and readmission rates for patients with DKA. Our study highlights the need for additional research to understand these differences and to identify the most cost-effective strategies for managing diabetes across the continuum of care.
Related Concept Videos
Diabetic Ketoacidosis l: Introduction
Diabetic Ketoacidosis ll: Pathophysiology
Complications of Diabetes Mellitus
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Acute Kidney Injury I: Introduction